Insmed：强劲上市及更大的峰值销售机遇（纳斯达克：INSM）
· seekingalpha.com
Insmed被评为强力买入，目标价175美元，较当前水平有约39%的上涨空间。
I have a strong interest in fundamental equity research, with a focus on companies with smaller market capitalizations. I look for underfollowed or misunderstoo...